{"id":"W4382011805","doi":"10.1002/ajh.27007","title":"Classification of accelerated phase chronic myeloid leukemia in the era of the <scp>BCR</scp>::<scp>ABL1</scp> tyrosine kinase inhibitors: A work in progress","year":2023,"lang":"en","type":"editorial","venue":"American Journal of Hematology","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"Takeda Canada; Ascentage Pharma; British Mycological Society; Novartis","keywords":"Myeloid leukemia; Tyrosine kinase; Cancer research; Medicine; Internal medicine; Receptor","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006220523,0.002459501,0.003115773,0.003014383,0.001435287,0.003492822,0.002674866,0.006795233,0.003513151],"category_scores_gemma":[0.01549129,0.0009156325,0.002216881,0.001183017,0.001526446,0.002932783,0.0007673191,0.01451385,0.003287063],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.002188055,"about_ca_system_score_gemma":0.002010677,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001901877,"about_ca_topic_score_gemma":0.004629395,"domain_scores_codex":[0.9981056,0.000429936,0.0004139585,0.0001952027,0.0007137565,0.0001414992],"domain_scores_gemma":[0.9832438,0.00561265,0.0008139533,0.0003391356,0.008228293,0.0017623],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001082045,0.00002105808,0.0001771106,0.0003699239,0.00004428968,0.0002572752,0.00001587667,0.00004998169,0.0001095274,0.0003195765,0.9828721,0.01565501],"study_design_scores_gemma":[0.0003577048,0.0001244011,0.002396004,0.00161418,0.0004682883,0.002927774,0.0001547638,0.0008620322,0.0004093806,0.002413183,0.9882091,0.00006311738],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"editorial","genre_gemma":"editorial","genre_scores_codex":[0.0001572829,0.010099,0.0002492163,0.03254525,0.9560423,0.00003202566,0.00006830746,0.00004869304,0.0007579408],"genre_scores_gemma":[0.001080561,0.01056744,0.0002758684,0.01477981,0.9704696,0.00002561157,0.00007978624,0.00002086384,0.00270056],"genre_candidate":"editorial","genre_consensus":"editorial","teacher_disagreement_score":0.006795233,"threshold_uncertainty_score":0.03289765,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01785556490048358,"score_gpt":0.3096090825842296,"score_spread":0.2917535176837461,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}